|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,147.00 INR | +2.28% |
|
-4.34% | -2.25% |
| 10/12 | Mankind Pharma receives tax penalty of 153.2 million rupees | RE |
| 01/12 | EQT Shows Interest in Vitabiotics - ET | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MANKIND PHARMA LIMITED | Other Pharmaceuticals | +2.28% | -4.34% | -2.25% | -16.25% | - | 946Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MANKIND Stock
- Charts Mankind Pharma Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition